Reporting and analysis of immunotherapy trials adverse events: what is going wrong, how to do better?
- 26 March 2024
- journal article
- letter
- Published by Elsevier in Annals of Oncology
- Vol. 35 (6) , 569-570
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Survival analysis for AdVerse events with VarYing follow-up times (SAVVY)—estimation of adverse event risksTrials, 2021
- Association Between Immune Checkpoint Inhibitors With Cardiovascular Events and Atherosclerotic PlaqueCirculation, 2020
- Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combinationNature Reviews Clinical Oncology, 2016